Drug utilization of temozolomide with or without antiepileptic drugs in patients with malignant gliomas in the Tuscany region

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/48421
• EU PAS number:
  EUPAS48420
• Study ID:
  48421
• Official title and acronym:
  Drug utilization of temozolomide with or without antiepileptic drugs in patients with malignant gliomas in the Tuscany region
• DARWIN EU® study:
  No
• Study countries:
  Italy
• Study status:
  Finalised

Research institutions and networks

Institutions

University of Siena

University of Pisa

University of Pisa Pisa, Azienda Ospedaliera Universitaria Senese Siena, University of Siena Siena

Study timelines

Date when funding contract was signed

Planned: 29/07/2022

Actual: 29/07/2022

Study start date

Planned: 29/07/2022

Actual: 29/07/2022

Date of final study report

Planned: 29/07/2022

Actual: 29/07/2022

Sources of funding

Other

More details on funding

No funding

Study protocol

Initial protocol

TMZ_encepp

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable